Markov Chain Monte Carlo Bayesian Analysis for Population Pharmacokinetics of Dasatinib in Japanese Adult Subjects with Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Markov Chain Monte Carlo Bayesian Analysis for Population Pharmacokinetics of Dasatinib in Japanese Adult Subjects with Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Published:2012 Issue:1 Volume:43 Page:29-41
ISSN:1882-8272
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

YOSHITSUGU Hiroyuki,IMAI Yasuhiko,SERIU Taku,HIRAOKA Masaki

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. 1) Sprycel^® (Dasatinib Tablets) Japan Package Insert, Bristol-Myers KK, Tokyo, Japan. Revised: 06/2011.

2. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

3. 3) Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4-ylamino ) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem. 2004; 47(27): 6658-61.

4. Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

5. The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics of Dasatinib in Healthy Subjects;Pharmaceuticals;2024-05-23

2. Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia;Pharmaceutical Research;2023-09-19

3. Therapeutic drug monitoring of oral targeted antineoplastic drugs;European Journal of Clinical Pharmacology;2020-11-09

4. Simultaneous Quantification of BCR-ABL and Bruton's Tyrosine Kinase Inhibitors in Dried Plasma Spots and Its Application to Clinical Sample Analysis;Therapeutic Drug Monitoring;2020-10-14

5. An Optimal Control Framework for the Automated Design of Personalized Cancer Treatments;Frontiers in Bioengineering and Biotechnology;2020-05-28